129 related articles for article (PubMed ID: 27297086)
21. PAK4 suppresses RELB to prevent senescence-like growth arrest in breast cancer.
Costa TDF; Zhuang T; Lorent J; Turco E; Olofsson H; Masia-Balague M; Zhao M; Rabieifar P; Robertson N; Kuiper R; Sjölund J; Spiess M; Hernández-Varas P; Rabenhorst U; Roswall P; Ma R; Gong X; Hartman J; Pietras K; Adams PD; Defilippi P; Strömblad S
Nat Commun; 2019 Aug; 10(1):3589. PubMed ID: 31399573
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of p21-activated kinase 4 expression suppresses the proliferation of Hep-2 laryngeal carcinoma cells via activation of the ATM/Chk1/2/p53 pathway.
Sun X; Liu B; Wang J; Li J; Ji WY
Int J Oncol; 2013 Feb; 42(2):683-9. PubMed ID: 23229348
[TBL] [Abstract][Full Text] [Related]
23. Differential role for PAK1 and PAK4 during the invadopodia lifecycle.
Nicholas NS; Pipili A; Lesjak MS; Wells CM
Small GTPases; 2019 Jul; 10(4):289-295. PubMed ID: 28301299
[TBL] [Abstract][Full Text] [Related]
24. Expression of aquaporin1, a water channel protein, in cytoplasm is negatively correlated with prognosis of breast cancer patients.
Qin F; Zhang H; Shao Y; Liu X; Yang L; Huang Y; Fu L; Gu F; Ma Y
Oncotarget; 2016 Feb; 7(7):8143-54. PubMed ID: 26812884
[TBL] [Abstract][Full Text] [Related]
25. p21-Activated kinase 4 predicts early recurrence and poor survival in patients with nonmetastatic clear cell renal cell carcinoma.
Liu W; Yang Y; Liu Y; Liu H; Zhang W; Xu L; Zhu Y; Xu J
Urol Oncol; 2015 May; 33(5):205.e13-21. PubMed ID: 25744653
[TBL] [Abstract][Full Text] [Related]
26. GL-1196 Suppresses the Proliferation and Invasion of Gastric Cancer Cells via Targeting PAK4 and Inhibiting PAK4-Mediated Signaling Pathways.
Zhang J; Zhang HY; Wang J; You LH; Zhou RZ; Zhao DM; Cheng MS; Li F
Int J Mol Sci; 2016 Apr; 17(4):470. PubMed ID: 27077843
[TBL] [Abstract][Full Text] [Related]
27. Oncogenic PAK4 regulates Smad2/3 axis involving gastric tumorigenesis.
Wang C; Li Y; Zhang H; Liu F; Cheng Z; Wang D; Wang G; Xu H; Zhao Y; Cao L; Li F
Oncogene; 2014 Jun; 33(26):3473-84. PubMed ID: 23934187
[TBL] [Abstract][Full Text] [Related]
28. Co-expression of S100A14 and S100A16 correlates with a poor prognosis in human breast cancer and promotes cancer cell invasion.
Tanaka M; Ichikawa-Tomikawa N; Shishito N; Nishiura K; Miura T; Hozumi A; Chiba H; Yoshida S; Ohtake T; Sugino T
BMC Cancer; 2015 Feb; 15():53. PubMed ID: 25884418
[TBL] [Abstract][Full Text] [Related]
29. Tumorigenic role of Pak4 in ovarian cancer and its correlation with immune infiltration.
Tang L; Ye H; Chen L; Dong W; Hu X; Yu L
BMC Med Genomics; 2024 May; 17(1):148. PubMed ID: 38807162
[TBL] [Abstract][Full Text] [Related]
30. Overexpressed PAK4 promotes proliferation, migration and invasion of choriocarcinoma.
Zhang HJ; Siu MK; Yeung MC; Jiang LL; Mak VC; Ngan HY; Wong OG; Zhang HQ; Cheung AN
Carcinogenesis; 2011 May; 32(5):765-71. PubMed ID: 21325635
[TBL] [Abstract][Full Text] [Related]
31. N-terminal interaction domain implicates PAK4 in translational regulation and reveals novel cellular localization signals.
Baldassa S; Calogero AM; Colombo G; Zippel R; Gnesutta N
J Cell Physiol; 2010 Sep; 224(3):722-33. PubMed ID: 20578242
[TBL] [Abstract][Full Text] [Related]
32. Interactions between FGFR2 and RSK2-implications for breast cancer prognosis.
Czaplinska D; Mieczkowski K; Supernat A; Skladanowski AC; Kordek R; Biernat W; Zaczek AJ; Romanska HM; Sadej R
Tumour Biol; 2016 Oct; 37(10):13721-13731. PubMed ID: 27476168
[TBL] [Abstract][Full Text] [Related]
33. Overexpression of a novel activator of PAK4, the CDK5 kinase-associated protein CDK5RAP3, promotes hepatocellular carcinoma metastasis.
Mak GW; Chan MM; Leong VY; Lee JM; Yau TO; Ng IO; Ching YP
Cancer Res; 2011 Apr; 71(8):2949-58. PubMed ID: 21385901
[TBL] [Abstract][Full Text] [Related]
34. Kaempferol as a Potential PAK4 Inhibitor in Triple Negative Breast Cancer: Extra Precision Glide Docking and Free Energy Calculation.
Arowosegbe MA; Amusan OT; Adeola SA; Adu OB; Akinola IA; Ogungbe BF; Omotuyi OI; Saibu GM; Ogunleye AJ; Kanmodi RI; Lugbe NE; Ogunmola OJ; Ajayi DC; Ogun SO; Oyende FO; Bello AO; Ishola PG; Obasieke PE
Curr Drug Discov Technol; 2020; 17(5):682-695. PubMed ID: 31441728
[TBL] [Abstract][Full Text] [Related]
35. Fatty acid binding protein 7 expression and its sub-cellular localization in breast cancer.
Alshareeda AT; Rakha EA; Nolan CC; Ellis IO; Green AR
Breast Cancer Res Treat; 2012 Jul; 134(2):519-29. PubMed ID: 22562177
[TBL] [Abstract][Full Text] [Related]
36. Knockdown of PAK4 or PAK1 inhibits the proliferation of mutant KRAS colon cancer cells independently of RAF/MEK/ERK and PI3K/AKT signaling.
Tabusa H; Brooks T; Massey AJ
Mol Cancer Res; 2013 Feb; 11(2):109-21. PubMed ID: 23233484
[TBL] [Abstract][Full Text] [Related]
37. DGCR6L, a novel PAK4 interaction protein, regulates PAK4-mediated migration of human gastric cancer cell via LIMK1.
Li X; Ke Q; Li Y; Liu F; Zhu G; Li F
Int J Biochem Cell Biol; 2010 Jan; 42(1):70-9. PubMed ID: 19778628
[TBL] [Abstract][Full Text] [Related]
38. Neogenin expression is inversely associated with breast cancer grade in ex vivo.
Xing W; Li Q; Cao R; Xu Z
World J Surg Oncol; 2014 Nov; 12():352. PubMed ID: 25416629
[TBL] [Abstract][Full Text] [Related]
39. P21-activated kinase 4--not just one of the PAK.
Dart AE; Wells CM
Eur J Cell Biol; 2013; 92(4-5):129-38. PubMed ID: 23642861
[TBL] [Abstract][Full Text] [Related]
40. p54(nrb)/NONO regulates lipid metabolism and breast cancer growth through SREBP-1A.
Zhu Z; Zhao X; Zhao L; Yang H; Liu L; Li J; Wu J; Yang F; Huang G; Liu J
Oncogene; 2016 Mar; 35(11):1399-410. PubMed ID: 26148231
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
